Loading…

Abbott plans to close its acquisition of Alere on October 3, 2017, after receiving anti-trust approvals. The deal is valued at $5.3 billion, down from the initial $5.8 billion. Abbott will divest certain assets to Siemens and Quidel.
“Creating the world’s leading point of care business will help Abbott meet the growing demand for fast, accurate and actionable information”massdevice.com
Summarized from public sources; check the original articles before acting on it.